List of publications using CP 466722 (Axon 1495) purchased from Axon Medchem

(Total 5 publication citations listed; updated JUNE 2016) 

Martens-de Kemp, S. R. (2014). Towards personalized and targeted treatment of head and neck cancer.
Węsierska-Gądek, J., & Heinzl, S. (2014). Interactions between ataxia telangiectasia mutated kinase inhibition, poly (ADP-ribose) polymerase-1 inhibition and BRCA1 status in breast cancer cells. Journal of cancer prevention, 19(2), 125.
*AZD2461, KU55933 nd CP466722 were purchased from Axon Medchem.
Lindenbergh-van der Plas, M., Martens-de Kemp, S. R., de Maaker, M., van Wieringen, W. N., Ylstra, B., Agami, R., ... & Brakenhoff, R. H. (2013). Identification of lethal microRNAs specific for head and neck cancer. Clin. Cancer Res. 2013
Read more:
Brakenhoff, R. H., Van Der Plas, M., De Kemp, S. R., Gommans, W. M., Prevost, G. P. A., Schaapveld, R. Q. J., & Cerisoli, F. (2012). U.S. Patent Application No. 14/367,837.

Farkas, T., Daugaard, M., & Jäättelä, M. (2011). Identification of small molecule inhibitors of phosphatidylinositol 3-kinase and autophagy. J. Biol. Chem. 2011, 286(45), 38904-38912.
Read more: 

(This is an incomplete list, updated JUNE 2016) 

Please wait...